摘要
目的探讨低分子肝素治疗急性心肌梗死的疗效及不良反应。方法176例住院患者随机分为观察组88例与对照组88例,两组均用阿司匹林口服及尿激酶确诊溶栓后,观察组用低分子肝素皮下注射。对照组用普通肝素皮下注射。结果在梗死后心绞痛、再梗死、左心衰、出血、死亡率等方面低分子肝素明显低于普通肝素(p<0.05);低分子肝素治疗急性心肌梗死血管再通率明显高于普通肝素(p<0.05)。结论急性心肌梗死常规治疗联用低分子肝素治疗效果显著,安全性高。
Objective To compare the curative effect and adverse reactions of low molecular heparin and heparin in acute myocardial infarction. Methods 176 patients were randomly divided into control group （ n = 88, urokinase, and aspirin combined with UFH injection） and observing group（ n = 88, urokinase, aspirin, combined with LMH injection）. Results The angina pectoris after the occurrence of myocardial infarction, left heart failure, blood bleeding, mortality, etc, of observing group were lower than those of control group （p 〈 0. 01 -0.05 ）, There was significant difference in adverse reactions between the 2 groups. Conclusion Routine treatment combined with LMH is more efficient and has higher safety.
出处
《现代医院》
2009年第2期46-47,共2页
Modern Hospitals
